Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
Published on: November 3, 2023
Development of a Cell-Based Fluorescence Polarization Biosensor Using Preproinsulin to Identify Compounds That Alter
Na Young Yi1, Qingping He1, Thomas B Caligan1
11 Biomanufacturing Research Institute and Technology Enterprise, Department of Pharmaceutical Sciences, North Carolina Central University , Durham, North Carolina.
A new fluorescent reporter system tracks insulin dynamics in pancreatic cells. This tool aids in discovering novel diabetes therapies by assessing insulin secretion and granule packaging, proving effective in high-throughput screening.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Diabetes affects 9.3% of the U.S. population, costing $245 billion annually.
- Current diabetes therapies have limitations in controlling blood glucose and enhancing insulin sensitivity.
- Innovative therapies for diabetes are urgently needed.
Purpose of the Study:
- To develop a fluorescent insulin reporter system (preproinsulin-mCherry, PPI-mCherry) for tracking live-cell insulin dynamics and secretion.
- To establish a high-throughput screening (HTS) method for sensing insulin granule packaging using a fluorescence polarization (FP)/Förster resonance energy transfer (FRET) biosensor.
- To assess the utility of this biosensor for drug discovery in diabetes.
Main Methods:
- Development of a preproinsulin-mCherry (PPI-mCherry) fluorescent reporter system.
- Utilizing a hybrid cell-based fluorescence polarization (FP)/internal FRET biosensor for insulin granule packaging.
- Testing the biosensor's response to bafilomycin, an inhibitor of insulin granule formation.
- Performing pilot high-throughput screening (HTS) of 1782 FDA-approved small molecules and natural products.
Main Results:
- The PPI-mCherry system successfully tracked live-cell insulin dynamics and secretion in pancreatic beta cells.
- Bafilomycin treatment significantly increased mCherry FP, correlated with decreased insulin granularity.
- Increased FP was attributed to inhibited self-Förster resonant energy transfer (homo-FRET) due to increased intermolecular distance.
- The biosensor demonstrated suitability for HTS with a Z'-factor of 0.52 ± 0.03.
Conclusions:
- The novel PPI-mCherry biosensor enables live-cell assessment of insulin dynamics and granule packaging.
- This system is compatible with conventional FP plate readers and suitable for HTS.
- The developed biosensor facilitates the discovery of novel therapeutic compounds for diabetes treatment.
More Related Videos
09:41Confocal Imaging of Neuropeptide Y-pHluorin: A Technique to Visualize Insulin Granule Exocytosis in Intact Murine and Human Islets
Published on: September 13, 2017
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018